Clinical Trial Update: BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy [Phase 3]

View source ↗

Summary

Phase 3 trial BioDFence G3 for full nerve-sparing robotic-assisted radical prostatectomy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• BioDFence G3

Snippet

Sponsor: AdventHealth | Conditions: Prostate Cancer, Prostatectomy | Phase 3 | Status: WITHDRAWN